The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Long-Term Cancer Survivorship

Multidisciplinary Care After Completion of Cancer Treatment

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Long-Term Cancer Survivorship?

Cancer survivorship encompasses the period from cancer diagnosis through the remainder of life, with the long-term phase typically defined as five or more years after primary treatment completion.

Comprehensive survivorship care addresses surveillance for recurrence, monitoring of treatment-related late effects (cardiotoxicity, neurotoxicity, endocrine, fertility, second malignancies), psychosocial well-being, and lifestyle modifications.

Treatment summaries and survivorship care plans (SCPs) developed by Institute of Medicine recommendations facilitate transition from oncology to primary care.

Symptoms

Cancer-related fatigue persisting beyond active treatment
Chemotherapy-induced peripheral neuropathy with chronic numbness/pain
Cardiotoxicity from anthracyclines or HER2-targeted therapy: heart failure, cardiomyopathy
Cognitive impairment ('chemo brain') with memory and concentration deficits
Lymphedema after axillary or pelvic node dissection
Endocrine sequelae: hypothyroidism, hypogonadism, premature menopause
Psychosocial: anxiety, depression, fear of recurrence, post-traumatic stress
Sexual dysfunction and altered body image

Risk Factors

Anthracycline-based chemotherapy (cumulative dose dependent cardiotoxicity)
Chest or mediastinal radiation (breast cancer, lymphoma) — secondary cancers, cardiac disease
Pelvic radiation — secondary cancers, infertility, bowel/bladder dysfunction
Allogeneic stem cell transplantation — graft-versus-host disease, secondary malignancies
Immunotherapy — chronic immune-related adverse events
Pediatric or young adult cancer — longer follow-up window, growth/development impact
Hereditary cancer syndromes — second cancer risk

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • New persistent symptoms after treatment completion (recurrence concern)
  • Cardiac symptoms in patient with prior anthracycline or chest radiation
  • Worsening neuropathy or new neurologic deficit
  • Persistent fatigue, sleep disturbance, or mood changes
  • Sexual dysfunction, infertility concerns, or hormonal symptoms
  • Routine surveillance visits per cancer-specific guidelines (e.g., annual mammogram, colonoscopy)

Treatment Methods

01
Individualized survivorship care plan with treatment summary
02
Cancer-specific surveillance per NCCN/ESMO guidelines
03
Late effects screening: echocardiography, lipid panel, thyroid function, bone density
04
Healthy lifestyle: nutrition counseling, exercise prescription, weight management, smoking cessation, alcohol moderation
05
Psychosocial support: counseling, support groups, mindfulness, antidepressants when indicated
06
Sexual health: counseling, hormone replacement when appropriate, vaginal estrogen, erectile dysfunction therapy
07
Vaccination: annual influenza, pneumococcal, HPV, herpes zoster
08
Secondary cancer screening per genetic risk and prior treatment exposures
09
Coordinated care between oncology and primary care with shared SCP

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.